CASI Pharmaceuticals, Inc. (CASIF)

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had revenue of $3.08M in the quarter ending September 30, 2025, a decrease of -60.54%. This brings the company's revenue in the last twelve months to $26.85M, up 21.72% year-over-year. In the year 2024, CASI Pharmaceuticals had annual revenue of $28.54M, down -15.77%.

• Revenue (ttm): 26.85M
• Revenue Growth: +21.72%
• P/S Ratio: 0.08
• Revenue / Employee: 115.22K
• Employees: 233
• Market Cap: 2.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.54M	-5.34M	-15.77%
Dec 31, 2023	33.88M	-9.23M	-21.41%
Dec 31, 2022	43.11M	12.94M	42.89%
Dec 31, 2021	30.17M	15.03M	99.25%
Dec 31, 2020	15.14M	11.01M	266.52%